Dr. Infante Talks About BRAF Mutation Testing

Jeffrey Infante, MD, director of drug development at the Sarah Cannon Research Institute talks about BRAF mutation testing.

Dr. Infante says that there is a subset of melanoma patients (about half) that have the BRAF mutation. He adds it can be tested easily around the country by multiple labs. If it turns out that a patient has a genetic change that is a BRAF mutation, there are drugs that can help the patient. While the drugs aren't FDA approved yet, there are many trials ongoing where patients can get access to those drugs.